MediMix had the privilege of consulting with two experts, Prof Duhoux from...
Prof Brian Rini gives an overview of the current treatment landscape in renal...
Prof Dr George Lau presented an exploratory post hoc analysis derived from the...
Trastuzumab deruxtecan (T-DXd) has been approved for the treatment of...
The plenary session at ASCO saw Prof Roy S. Herbst of the Yale Cancer Center...
Prof Eric Van Cutsem and Prof Deborah Schrag discuss the PROSPECT study. This...
The benefit of immunotherapy in patients with metastatic breast cancer is...
The possibility of performing surgical resection for non-small-cell lung cancer...
The CheckMate 9LA study has already demonstrated the significant benefit of...
During the 2023 edition of ELCC, Dr Mariana Brandao from the Institut Jules...